TY - JOUR
T1 - A metabolic profile of all-cause mortality risk identified in an observational study of 44,168 individuals
AU - Deelen, Joris
AU - Kettunen, Johannes
AU - Fischer, Krista
AU - van der Spek, Ashley
AU - Trompet, Stella
AU - Kastenmüller, Gabi
AU - Boyd, Andy
AU - Zierer, Jonas
AU - van den Akker, Erik B.
AU - Ala-Korpela, Mika
AU - Amin, Najaf
AU - Demirkan, Ayse
AU - Ghanbari, Mohsen
AU - van Heemst, Diana
AU - Ikram, M. Arfan
AU - van Klinken, Jan Bert
AU - Mooijaart, Simon P.
AU - Peters, Annette
AU - Salomaa, Veikko
AU - Sattar, Naveed
AU - Spector, Tim D.
AU - Tiemeier, Henning
AU - Verhoeven, Aswin
AU - Waldenberger, Melanie
AU - Würtz, Peter
AU - Davey Smith, George
AU - Metspalu, Andres
AU - Perola, Markus
AU - Menni, Cristina
AU - Geleijnse, Johanna M.
AU - Drenos, Fotios
AU - Beekman, Marian
AU - Jukema, J. Wouter
AU - van Duijn, Cornelia M.
AU - Slagboom, P. Eline
PY - 2019/12/1
Y1 - 2019/12/1
N2 - Predicting longer-term mortality risk requires collection of clinical data, which is often cumbersome. Therefore, we use a well-standardized metabolomics platform to identify metabolic predictors of long-term mortality in the circulation of 44,168 individuals (age at baseline 18–109), of whom 5512 died during follow-up. We apply a stepwise (forward-backward) procedure based on meta-analysis results and identify 14 circulating biomarkers independently associating with all-cause mortality. Overall, these associations are similar in men and women and across different age strata. We subsequently show that the prediction accuracy of 5- and 10-year mortality based on a model containing the identified biomarkers and sex (C-statistic = 0.837 and 0.830, respectively) is better than that of a model containing conventional risk factors for mortality (C-statistic = 0.772 and 0.790, respectively). The use of the identified metabolic profile as a predictor of mortality or surrogate endpoint in clinical studies needs further investigation.
AB - Predicting longer-term mortality risk requires collection of clinical data, which is often cumbersome. Therefore, we use a well-standardized metabolomics platform to identify metabolic predictors of long-term mortality in the circulation of 44,168 individuals (age at baseline 18–109), of whom 5512 died during follow-up. We apply a stepwise (forward-backward) procedure based on meta-analysis results and identify 14 circulating biomarkers independently associating with all-cause mortality. Overall, these associations are similar in men and women and across different age strata. We subsequently show that the prediction accuracy of 5- and 10-year mortality based on a model containing the identified biomarkers and sex (C-statistic = 0.837 and 0.830, respectively) is better than that of a model containing conventional risk factors for mortality (C-statistic = 0.772 and 0.790, respectively). The use of the identified metabolic profile as a predictor of mortality or surrogate endpoint in clinical studies needs further investigation.
UR - http://www.scopus.com/inward/record.url?scp=85070837796&partnerID=8YFLogxK
U2 - 10.1038/s41467-019-11311-9
DO - 10.1038/s41467-019-11311-9
M3 - Article
AN - SCOPUS:85070837796
SN - 2041-1723
VL - 10
JO - Nature Communications
JF - Nature Communications
IS - 1
M1 - 3346
ER -